Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Dose Finding in Japanese Subjects with IGT
NCT01405911Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sitagliptin in impaired glucose tolerance (IGT), sponsored by Merck & Co.. Started Aug 2011; status: completed.
02
Drugs
sitagliptin
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT01405911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01405911.